Gallery of new files
Jump to navigation
Jump to search
This special page shows the last uploaded files.
-
-
Table 4 Clinical Data Trial 1 and 2.png Tejasvi Aryaputra
16:09, 20 January 2023
1,328 × 1,226; 254 KB
-
-
-
Ibrexafungerp Table 1 Adverse Reactions (Trials 1 and 2).png Tejasvi Aryaputra
16:09, 20 January 2023
1,296 × 516; 95 KB
-
-
Aducanumab-avwa Table 8 Study 2 Biomarkers.png Tejasvi Aryaputra
21:59, 10 January 2023
1,006 × 990; 196 KB
-
Aducanumab-avwa Table 7 Clinical Results Study 1.png Tejasvi Aryaputra
21:59, 10 January 2023
1,000 × 1,318; 214 KB
-
Aducanumab-avwa Table 6 Study 1 Biomarkers.png Tejasvi Aryaputra
21:59, 10 January 2023
1,350 × 1,318; 231 KB
-
Aducanumab-avwa Table 5 Adverse Reactions.png Tejasvi Aryaputra
21:59, 10 January 2023
1,314 × 1,256; 214 KB
-
Aducanumab-avwa Table 4 ARIA Classification.png Tejasvi Aryaputra
21:59, 10 January 2023
1,326 × 926; 176 KB
-
Aducanumab-avwa Table 3 Dosing Modifciations.png Tejasvi Aryaputra
21:58, 10 January 2023
1,308 × 748; 147 KB
-
Aducanumab-avwa Table 2 Dosing Monitoring.png Tejasvi Aryaputra
21:58, 10 January 2023
1,330 × 718; 136 KB
-
-
-
-
-
Aducanumab-avwa Figure 4 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,014 × 944; 305 KB
-
Aducanumab-avwa Figure 3 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,012 × 990; 219 KB
-
Aducanumab-avwa Figure 2 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,350 × 1,206; 268 KB
-
Aducanumab-avwa Figure 1 Clinical Studies.png Tejasvi Aryaputra
21:57, 10 January 2023
1,352 × 1,318; 350 KB
-
Aducanumab-avwa Drug Label (3 mL).png Tejasvi Aryaputra
21:56, 10 January 2023
1,362 × 1,100; 583 KB
-
Aducanumab-avwa Drug Label (1.7 mL).png Tejasvi Aryaputra
21:56, 10 January 2023
1,352 × 1,102; 578 KB
-
-
-
-
-
-
Rylaze Table 2 Dosage Modifications.png Tejasvi Aryaputra
13:46, 3 January 2023
1,006 × 1,498; 348 KB
-
-
-
-
-
Upper GI bleeding. Adapted from ACG Clinical Guideline- Upper Gastrointestinal and Ulcer Bleeding.png Jair Basantes de la Calle
13:54, 29 December 2022
1,920 × 1,080; 201 KB
-
Stage A and Stage B recommendations for HF. Adapted from 2022 AHA-ACC-HFSA Guideline for the Management of Heart Failure.png Jair Basantes de la Calle
21:21, 8 December 2022
1,920 × 1,080; 144 KB
-
Recommendation for blood pressure management. Adapted from the 2019 ACC-AHA Guideline on the Primary Prevention of Cardiovascular Disease. .png Jair Basantes de la Calle
19:24, 8 December 2022
1,920 × 1,080; 91 KB
-
Primary Prevention of ASCVD per age group.png Jair Basantes de la Calle
18:28, 8 December 2022
1,920 × 1,080; 318 KB
-
-
Diagnostic Algorithm for HF and EF-Based Classification.png Jair Basantes de la Calle
12:57, 28 November 2022
1,678 × 1,080; 171 KB
-
-
-
-
Finerenone Table 4 Clinical Studies.png Tejasvi Aryaputra
00:16, 6 September 2022
608 × 1,450; 175 KB
-
Finerenone Table 3 Adverse Reactions.png Tejasvi Aryaputra
00:15, 6 September 2022
1,004 × 656; 85 KB
-
Finerenone Table 2 Dosage Adjustments.png Tejasvi Aryaputra
00:15, 6 September 2022
1,142 × 898; 147 KB
-
-
-
-
Finerenone Figure 2 Clinical Studies.png Tejasvi Aryaputra
00:15, 6 September 2022
1,290 × 1,080; 519 KB
-
Finerenone Figure 1 Clincal Studies.png Tejasvi Aryaputra
00:15, 6 September 2022
1,326 × 1,158; 550 KB
.png){kind=small}
.png)
.png)
